가상 임상시험 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 10.9%로 196억 7,000만 달러로 성장합니다. 예측기간 성장의 배경으로는 분산 임상시험 채용 확대, 웨어러블 기기 및 기타 원격 모니터링 기기의 사용 증가, 원격 의료 서비스 확대, 가상 시험 방법에 대한 규제 당국 지원, 시험 시행에 있어서의 비용과 시간의 효율화 등이 있습니다. 예측기간의 주요 동향으로는 임상시험에서의 인공지능과 머신러닝의 이용 증가, 전자인폼드 콘센트(eConsent) 이용 증가, 가상 임상시험 플랫폼과 기술의 성장, 제약기업과 기술공급자와의 연계, 실세계의 근거의 중시, 데이터 수집의 분산화 등이 있습니다.
새로운 백신과 신약의 연구개발에 대한 정부와 제약회사의 투자가 증가하고 있는 것이 가상 임상시험 시장의 성장에 박차를 가하고 있습니다. 의료 산업의 R&D 부서에서는 의약품 및 제품의 품질 보증 및 임상 데이터 관리를 강화하기 위해 가상 임상시험 솔루션 및 서비스의 도입이 진행되고 있습니다. McKinsey가 발표한 기사에 따르면 COVID-19의 대유행은 제약기업에 의한 분산형 임상시험의 채용을 가속화시켜 가상 임상시험의 큰 이점을 보여 환자와 의사 모두의 경험을 향상시켰습니다. 그러므로 정부와 제약 기업에 의한 새로운 백신과 신약 개발에 대한 투자 확대는 가상 임상시험의 확대를 뒷받침하고 있습니다.
임상시험 건수 증가가 예상되기 때문에 가상 임상시험 시장의 성장은 당분간 지속될 것으로 예상됩니다. 임상시험은 새로운 치료, 개입, 약물의 안전성, 효능 및 잠재적 이점을 평가하는 것을 목표로 하는 인간을 대상으로 하는 본질적인 조사 연구입니다. 임상시험 증가는 보다 효율적이고 비용 효율적이며 환자 친화적인 임상 연구를 수행하는 방법을 제공하는 가상 임상시험의 확대에 길을 열었습니다. 2023년 5월에 ClinicalTrials.gov가 보고한 바와 같이, 등록된 임상시험 수는 2022년 39만 9,499건에서 미국 전 50개 주와 세계 221개국에서 43만 7,533건으로 증가했습니다. 이러한 임상시험의 급증은 미국 이외에도 상당수가 실시되고 있어 가상 임상시험 시장의 성장을 뒷받침하는 자세입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 가상 임상시험 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인, 성장 억제요인)
- 최종 이용 산업의 분석
- 세계의 가상 임상시험 시장 : 성장률 분석
- 세계의 가상 임상시험 시장 실적 : 규모와 성장(2019-2024년), 10억 달러
- 세계의 가상 임상시험 시장 예측 : 규모와 성장(2024-2029년, 2034년), 10억 달러
- 세계의 가상 임상시험 총 주소 가능 시장(TAM)
제6장 시장 세분화
- 세계의 가상 임상시험 시장 : 디자인별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 관찰 임상시험
- 중재 임상시험
- 확장 접근 임상시험
- 세계의 가상 임상시험 시장 : 위상별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- Phase I
- Phase II
- Phase III
- Phase IV
- 세계의 가상 임상시험 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 중추신경계
- 자가면역/염증
- 심혈관 질환
- 대사·내분비학
- 감염성 질환
- 종양학
- 비뇨생식기
- 안과
- 기타
- 세계의 가상 임상시험 시장 : 관찰 시험의 서브 세분화 : 디자인별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 전향적 코호트 연구
- 후향적 연구
- 사례 대조군 연구
- 세계의 가상 임상시험 시장 : 개입 시험의 서브 세분화 : 디자인별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 무작위 대조 임상시험(RCT)
- 비무작위 임상시험
- 적응증 임상시험
- 세계의 가상 임상시험 시장 : 확장 액세스 시험의 서브 세분화 : 디자인별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 단일 환자에 대한 확장 액세스
- 여러 환자에 대한 확장 액세스
- 치료 목적 사용 프로그램
제7장 지역별·국가별 분석
- 세계의 가상 임상시험 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 세계의 가상 임상시험 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 가상 임상시험 시장 : 경쟁 구도
- 가상 임상시험 시장 : 기업 프로파일
- ICON plc 개요, 제품 및 서비스, 전략 및 재무 분석
- Parexel International Pvt. Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- IQVIA Holdings Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Covance Research Products Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Pharmaceutical Research Associates Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Medidata Solution Inc.
- Oracle Corporation
- Clario Tech Ltd.
- Medable Inc.
- Science 37 Holdings Inc.
- THREAD Research
- Clinical Ink Inc.
- Veeva Systems Inc.
- Clinerion Ltd.
- CRF Health Group Limited
- Royal Castor Products Limited
- Crio Inc.
- Deep Lens Inc.
- Florence Healthcare Inc.
- goBalto Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 가상 임상시험 시장(2029년) : 새로운 기회를 제공하는 국가
- 가상 임상시험 시장(2029년) : 새로운 기회를 제공하는 부문
- 가상 임상시험 시장(2029년) : 성장 전략
제36장 부록
KTH
Virtual clinical trials, also known as remote or decentralized clinical trials, involve the integration of digital health technologies to enable remote participation beyond the traditional clinical trial sites. Utilizing tools such as tablets, smartphone apps, or wearable sensors, these trials bring about a significant shift in clinical research methodology, creating a more patient-centric ecosystem.
The primary design types of virtual clinical trials comprise observational trials, interventional trials, and expanded access trials. Observational trials specifically pertain to solutions and services used in this context. Observational studies aim to understand what happens to individuals in various scenarios, with the study team observing participants without directly influencing the treatments they receive. Virtual clinical trials find application across different phases, including Phase I, Phase II, Phase III, and Phase IV. They are employed in clinical trials focused on drugs and devices used in the treatment of various medical conditions such as CNS disorders, autoimmune/inflammatory diseases, cardiovascular diseases, metabolic/endocrinology disorders, infectious diseases, oncology, genitourinary conditions, ophthalmology, and others.
The virtual clinical trials market research report is one of a series of new reports from The Business Research Company that provides virtual clinical trials market statistics, including virtual clinical trials industry global market size, regional shares, competitors with a virtual clinical trials market share, detailed virtual clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical trials industry. This virtual clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The virtual clinical trials market size has grown strongly in recent years. It will grow from $11.91 billion in 2024 to $12.99 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased costs of clinical trials, growing need for patient-centric trials, increased demand for remote monitoring, growing adoption of digital technologies in clinical trials, increased need for efficient and cost-effective clinical trial.
The virtual clinical trials market size is expected to see rapid growth in the next few years. It will grow to $19.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to growing adoption of decentralized clinical trials, increasing use of wearables and other remote monitoring devices, expansion of telehealth services, regulatory support for virtual trial methodologies, cost and time efficiency in trial conduct. Major trends in the forecast period include increasing use of artificial intelligence and machine learning in clinical trials, increased use of electronic informed consent (econsent), growth in virtual trial platforms and technologies, collaboration between pharmaceutical companies and technology providers, focus on real-world evidence and decentralized data collection.
The rising investments from governments and pharmaceutical companies in research and development for new vaccines and drugs are fueling the growth of the virtual clinical trials market. R&D departments within the medical industry are increasingly adopting virtual clinical trial solutions and services to enhance quality assurance and clinical data management for drugs and their products. According to an article published by McKinsey, the COVID-19 pandemic has accelerated the adoption of decentralized clinical trials by pharmaceutical companies, emphasizing the significant advantages of virtual trials and enhancing the experience for both patients and physicians. Therefore, the growing investments by governments and pharmaceutical companies in the development of new vaccines and drugs are driving the expansion of virtual clinical trials.
The anticipated increase in the number of clinical trials is expected to drive the growth of the virtual clinical trials market in the foreseeable future. Clinical trials, essential research studies involving human participants, aim to assess the safety, efficacy, and potential benefits of new medical treatments, interventions, or drugs. The growth in clinical trials has paved the way for the expansion of virtual clinical trials, offering a more efficient, cost-effective, and patient-friendly approach to conducting clinical research. As reported by ClinicalTrials. gov in May 2023, the number of registered clinical trial studies has risen from 399,499 in 2022 to 437,533 across all 50 states of the United States and 221 countries globally. This surge in clinical trials, with a significant number taking place outside the U. S., is poised to drive the growth of the virtual clinical trials market.
Technological advancement stands out as a prominent trend gaining traction in the virtual clinical trials market. Key companies in this market are actively focusing on delivering technologically advanced solutions to meet the rapidly growing industry demands and fortify their market positions. These companies are incorporating next-generation virtual clinical technologies, including wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and more into their services. For instance, in April 2022, Unlearn. AI, a U. S. -based startup, announced the launch of a novel digital twin RCTs technology for clinical trials, utilizing AI and historical data to enable smaller control groups while maintaining statistical power and generating evidence suitable for regulatory decisions.
Major companies in the virtual clinical trials market are intensifying their efforts in forming partnerships to enhance virtual clinical trials. Strategic partnerships, involving companies leveraging each other's strengths and resources for mutual benefits, are increasingly prevalent. For example, in July 2021, Novotech, an Australia-based clinical research organization (CRO), collaborated with ObvioHealth, a U. S. -based provider of digital and virtual clinical trials, establishing Novotech as ObvioHealth's preferred CRO for hybrid and virtual studies in the region. This partnership is set to bolster Novotech's capabilities in conducting virtual clinical trials and enhance ObvioHealth's presence in the Asia Pacific region.
In February 2024, PCM Trials, a home health care service based in the U.S., acquired EmVenio Research Inc. for an undisclosed amount. This acquisition is intended to enhance both PCM Trials' and EmVenio's capabilities in recruiting and retaining diverse populations for clinical research, which is essential for regulatory approval. The partnership gives PCM Trials access to EmVenio's site network that targets underserved communities, promoting patient-centric clinical trials and improving retention and diversity. EmVenio Research Inc. is a U.S.-based company dedicated to enabling virtual clinical trials through advanced technology and data analytics to create more efficient research processes.
Major companies operating in the virtual clinical trials market include ICON plc, Parexel International Pvt. Ltd., IQVIA Holdings Inc., Covance Research Products Inc., Pharmaceutical Research Associates Inc., Medidata Solution Inc., Oracle Corporation, Clario Tech Ltd., Medable Inc., Science 37 Holdings Inc., THREAD Research, Clinical Ink Inc., Veeva Systems Inc., Clinerion Ltd., CRF Health Group Limited, Royal Castor Products Limited, Crio Inc., Deep Lens Inc., Florence Healthcare Inc., goBalto Inc., Medrio Inc., Mint Medical Ltd., Mytrus Inc., OpenClinica LLC, PatientWing, RealTime-CTMS LLC, Reify Health, Sanguine Biosciences Inc., TriNetX Inc., VirTrial LLC
North America was the largest region in the virtual clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the virtual clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
The virtual clinical trials market includes revenues earned by entities by providing services such as pilot studies and feasibility studies, prevention trials, screening trials, treatment trials, multi-arm multi-stage (mams) trials, cohort studies, case control studies, and cross sectional studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Virtual Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on virtual clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for virtual clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The virtual clinical trials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Design: Observational Trials; Interventional Trials; Expanded Access Trials
- 2) By Phases: Phase I; Phase II; Phase III; Phase IV
- 3) By Indication: CNS; Autoimmune Or Inflammation; Cardiovascular Disease; Metabolic Or Endocrinology; Infectious Disease; Oncology; Genitourinary; Ophthalmology; Other Indications
- Subsegments:
- 1) By Observational Trials: Prospective Cohort Studies; Retrospective Studies; Case-Control Studies
- 2) By Interventional Trials: Randomized Controlled Trials (RCTs); Non-Randomized Trials; Adaptive Trials
- 3) By Expanded Access Trials: Single-Patient Expanded Access; Multi-Patient Expanded Access; Compassionate Use Programs
- Companies Mentioned: ICON plc; Parexel International Pvt. Ltd.; IQVIA Holdings Inc.; Covance Research Products Inc.; Pharmaceutical Research Associates Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Virtual Clinical Trials Market Characteristics
3. Virtual Clinical Trials Market Trends And Strategies
4. Virtual Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Virtual Clinical Trials Growth Analysis And Strategic Analysis Framework
- 5.1. Global Virtual Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Virtual Clinical Trials Market Growth Rate Analysis
- 5.4. Global Virtual Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Virtual Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Virtual Clinical Trials Total Addressable Market (TAM)
6. Virtual Clinical Trials Market Segmentation
- 6.1. Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Observational Trials
- Interventional Trials
- Expanded Access Trials
- 6.2. Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Phase I
- Phase II
- Phase III
- Phase IV
- 6.3. Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- CNS
- Autoimmune/Inflammation
- Cardiovascular Disease
- Metabolic/Endocrinology
- Infectious Disease
- Oncology
- Genitourinary
- Ophthalmology
- Other Indications
- 6.4. Global Virtual Clinical Trials Market, Sub-Segmentation Of Observational Trials, By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prospective Cohort Studies
- Retrospective Studies
- Case-Control Studies
- 6.5. Global Virtual Clinical Trials Market, Sub-Segmentation Of Interventional Trials, By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Randomized Controlled Trials (RCTs)
- Non-Randomized Trials
- Adaptive Trials
- 6.6. Global Virtual Clinical Trials Market, Sub-Segmentation Of Expanded Access Trials, By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Patient Expanded Access
- Multi-Patient Expanded Access
- Compassionate Use Programs
7. Virtual Clinical Trials Market Regional And Country Analysis
- 7.1. Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Virtual Clinical Trials Market
- 8.1. Asia-Pacific Virtual Clinical Trials Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Virtual Clinical Trials Market
- 9.1. China Virtual Clinical Trials Market Overview
- 9.2. China Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Virtual Clinical Trials Market
- 10.1. India Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Virtual Clinical Trials Market
- 11.1. Japan Virtual Clinical Trials Market Overview
- 11.2. Japan Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Virtual Clinical Trials Market
- 12.1. Australia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Virtual Clinical Trials Market
- 13.1. Indonesia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Virtual Clinical Trials Market
- 14.1. South Korea Virtual Clinical Trials Market Overview
- 14.2. South Korea Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Virtual Clinical Trials Market
- 15.1. Western Europe Virtual Clinical Trials Market Overview
- 15.2. Western Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Virtual Clinical Trials Market
- 16.1. UK Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Virtual Clinical Trials Market
- 17.1. Germany Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Virtual Clinical Trials Market
- 18.1. France Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Virtual Clinical Trials Market
- 19.1. Italy Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Virtual Clinical Trials Market
- 20.1. Spain Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Virtual Clinical Trials Market
- 21.1. Eastern Europe Virtual Clinical Trials Market Overview
- 21.2. Eastern Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Virtual Clinical Trials Market
- 22.1. Russia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Virtual Clinical Trials Market
- 23.1. North America Virtual Clinical Trials Market Overview
- 23.2. North America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Virtual Clinical Trials Market
- 24.1. USA Virtual Clinical Trials Market Overview
- 24.2. USA Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Virtual Clinical Trials Market
- 25.1. Canada Virtual Clinical Trials Market Overview
- 25.2. Canada Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Virtual Clinical Trials Market
- 26.1. South America Virtual Clinical Trials Market Overview
- 26.2. South America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Virtual Clinical Trials Market
- 27.1. Brazil Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Virtual Clinical Trials Market
- 28.1. Middle East Virtual Clinical Trials Market Overview
- 28.2. Middle East Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Virtual Clinical Trials Market
- 29.1. Africa Virtual Clinical Trials Market Overview
- 29.2. Africa Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Virtual Clinical Trials Market Competitive Landscape And Company Profiles
- 30.1. Virtual Clinical Trials Market Competitive Landscape
- 30.2. Virtual Clinical Trials Market Company Profiles
- 30.2.1. ICON plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Parexel International Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Covance Research Products Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Pharmaceutical Research Associates Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Virtual Clinical Trials Market Other Major And Innovative Companies
- 31.1. Medidata Solution Inc.
- 31.2. Oracle Corporation
- 31.3. Clario Tech Ltd.
- 31.4. Medable Inc.
- 31.5. Science 37 Holdings Inc.
- 31.6. THREAD Research
- 31.7. Clinical Ink Inc.
- 31.8. Veeva Systems Inc.
- 31.9. Clinerion Ltd.
- 31.10. CRF Health Group Limited
- 31.11. Royal Castor Products Limited
- 31.12. Crio Inc.
- 31.13. Deep Lens Inc.
- 31.14. Florence Healthcare Inc.
- 31.15. goBalto Inc.
32. Global Virtual Clinical Trials Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Virtual Clinical Trials Market
34. Recent Developments In The Virtual Clinical Trials Market
35. Virtual Clinical Trials Market High Potential Countries, Segments and Strategies
- 35.1 Virtual Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Virtual Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Virtual Clinical Trials Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
